T
ABBV icon

Tidemark’s AbbVie ABBV Stock Holding History

Tidemark’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$82.9K Sell
330
-1
-0.3% -$215 0.02% 239
2026
Q1 		$71.9K Buy
331
+26
+9% +$5.77K 0.02% 227
2025
Q4 		$69.6K Sell
305
-9
-3% -$2.05K 0.02% 208
2025
Q3 		$72.6K Buy
314
+1
+0.3% +$204 0.02% 208
2025
Q2 		$58.2K Buy
313
+9
+3% +$1.67K 0.02% 223
2025
Q1 		$63.8K Hold
304
– – 0.02% 211
2024
Q4 		$54.1K Buy
304
+32
+12% +$5.88K 0.02% 226
2024
Q3 		$53.8K Sell
272
-1
-0.4% -$187 0.02% 218
2024
Q2 		$46.9K Sell
273
-84
-24% -$13.9K 0.02% 224
2024
Q1 		$65.1K Sell
357
-236
-40% -$40.7K 0.04% 208
2023
Q4 		$91.9K Buy
+593
New +$86.5K 0.06% 170

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Tidemark's ABBV Position: Q2 2026 in Review

Tidemark reduced its AbbVie (ABBV) stake by 0.3% in Q2 2026, selling an estimated $215 and leaving 330 shares worth $82.9K. The position accounts for 0.02% of the portfolio, ranked #239.

Tidemark first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. The position peaked at $91.9K in Q4 2023. 4,188 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Tidemark held 330 shares of AbbVie worth $82.9K as of Q2 2026.
  • Tidemark sold 1 AbbVie share in Q2 2026, an estimated $215.
  • AbbVie made up 0.02% of Tidemark's portfolio in Q2 2026, its #239 holding.
  • Tidemark first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • Tidemark's AbbVie position peaked at $91.9K in Q4 2023.
  • 4,188 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Tidemark's 13F filing for Q2 2026, filed 10 Aug 2026.